Literature DB >> 25559340

Quantitative methods for prediction of the effect of cytochrome P450 gene polymorphisms on substrate drug exposure.

Sylvain Goutelle1, Michel Tod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25559340     DOI： 10.1007/s40262-014-0217-3

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  6 in total

Review 1.  Impact of cytochrome P450 2C19 polymorphisms on citalopram/escitalopram exposure: a systematic review and meta-analysis.

Authors:  Ming Chang; Gunnel Tybring; Marja-Liisa Dahl; Jonatan D Lindh
Journal:  Clin Pharmacokinet       Date:  2014-09       Impact factor: 6.447

2.  CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.

Authors:  Johanna Weiss; Magdalena Maria Ten Hoevel; Jürgen Burhenne; Ingeborg Walter-Sack; Michael Marcus Hoffmann; Jens Rengelshausen; Walter E Haefeli; Gerd Mikus
Journal:  J Clin Pharmacol       Date:  2008-11-25       Impact factor: 3.126

3.  Impact of genetic polymorphism on drug-drug interactions mediated by cytochromes: a general approach.

Authors:  Michel Tod; Christina Nkoud-Mongo; François Gueyffier
Journal:  AAPS J       Date:  2013-09-12       Impact factor: 4.009

4.  Genotype-based quantitative prediction of drug exposure for drugs metabolized by CYP2D6.

Authors:  M Tod; S Goutelle; M C Gagnieu
Journal:  Clin Pharmacol Ther       Date:  2011-08-24       Impact factor: 6.875

5.  In vivo quantitative prediction of the effect of gene polymorphisms and drug interactions on drug exposure for CYP2C19 substrates.

Authors:  Sylvain Goutelle; Laurent Bourguignon; Nathalie Bleyzac; Johanna Berry; Fannie Clavel-Grabit; Michel Tod
Journal:  AAPS J       Date:  2013-01-15       Impact factor: 4.009

6.  Quantitative prediction of the impact of drug interactions and genetic polymorphisms on cytochrome P450 2C9 substrate exposure.

Authors:  Anne-Charlotte Castellan; Michel Tod; François Gueyffier; Mélanie Audars; Fredéric Cambriels; Behrouz Kassaï; Patrice Nony
Journal:  Clin Pharmacokinet       Date:  2013-03       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.